Facebook link Linked In link You Tube link

Important Dates and Deadlines  Submit an Abstract
Abstract submissions open       Monday, November 3, 2014
Abstract submission deadline  Wednesday, January 28, 2015
All abstract presenters must be registered for FOCIS 2014 (or abstract may be withdrawn)  Wednesday, April 1, 2015 
Late-breaking abstract submission deadline  Wednesday, April 1, 2015
FOCIS 2015  June 24-27, 2015

Abstract Fee
There is a $30 non-refundable submission fee per abstract for FOCIS non-members. This fee is waived for presenting authors who are FOCIS members. Join FOCIS prior to abstract submission to ensure that your fee is waived. If you submit your abstract prior to joining FOCIS, your abstract fee will not be refunded. Please note: only the presenting author should submit abstracts.

Travel Awards - NEW for 2015!
Travel awards are available to FOCIS members only who submit an abstract and are chosen for presentation at FOCIS 2015. The number and amount of the awards is based upon several factors including geographic location, placement of abstract within the FOCIS program and funds available.

Abstract Placement 
The FOCIS Scientific Program Committee has sole discretion regarding placement of abstracts within the FOCIS program. Abstracts are considered for either oral or poster presentations. Please indicate your preference for oral or poster presentation format during online submission.

FOCIS Poster Session

Abstract Presentation
Presenting authors must submit the abstract and must be prepared to present the abstract at FOCIS 2015 should it be accepted. Posters will not be allowed without an accompanying presenter.
• Posters should fit on a poster board that is 4 feet wide (horizontal) by 4 feet high (vertical).
• Posters MUST be removed from the poster area immediately following your session.
• Posters remaining in the hall after the poster session will be disposed of.

Abstract Publication
Abstracts accepted for presentation and properly registered by April 1, 2015 will be published as a supplement to the Clinical Immunology journal and in PDF format on the FOCIS website.

Changes and Withdrawals
Please review your submission carefully. No revisions, including author information and/or new data, will be accepted after the deadline. Withdrawals of abstracts must be received in writing before April 1, 2015.

Disclosure
All presenting authors must submit a completed disclosure form. This policy has been established in cooperation with ACCME guidelines.

Eligibility
FOCIS members, members of any of the FOCIS Member Societies or FOCIS Centers of Excellence, as well as non-members are eligible to submit abstracts.

Graphics/Charts
Graphic elements, such as charts, pictures, etc. may not be included in abstract submission.

Notification
Notification of acceptance or rejection will be sent the week of March 9th. Late breaking abstract presenting authors will be notified the week of April 7th. If your abstract’s contact author does not receive notification of your abstract's status, please contact the FOCIS Executive Office at (414) 359-1670 or This email address is being protected from spambots. You need JavaScript enabled to view it.

Registration Policy
Abstract submitters who are accepted for a poster presentation at FOCIS 2015 must register to attend the meeting by April 1, 2015 for their abstracts to be included in the FOCIS 2015 Abstract Supplement and their posters to be scheduled in a poster session. Submitters who are accepted, but do not register will be considered withdrawals, and will not be included in the Scientific Program or online Abstract Supplement.

Review Process
Each abstract is blinded and peer-reviewed by three members of the Abstract Review Committee.

Sample Abstract
(1) Foxp3 (Scurfy) Mutation Greatly Accelerates Diabetes in Insulin-specific TCR Transgenic Mice

(2) Jean Jasinski1, Maki Nakayama1, Kelly Johnson1, Liping Yu1, George Eisenbarth1, University of Colorado Health Sciences Center, Barbara Davis Center, Aurora, CO

(3) Previously we developed and described the development of a transgenic mouse expressing an insulin-specific (ins2 B:9–23) T cell receptor mouse model (BDC12-4.1). This pathogenic model exhibited spontaneous diabetes development on a backcross-1 (FVB×NOD)×NOD background. (Abstract is continued; this is a sample only.)

(1) = Title: Mixed case, no punctuation at end.

(2) = Author Information: In proper author order with all institutional information included.

(3) = Abstract Body: 250 word count, not including abstract title or author information.

**Charts or graphics of any kind may not be included in abstract submission. **

Questions? Please contact the Executive Office by sending an email to This email address is being protected from spambots. You need JavaScript enabled to view it.  or by calling (414) 359-1670.

Share